BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs2476601
,
EGFR
,
calcium channel activity
,
Breast Cancer
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BTCS
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast SKBR3 cells treated with ligand perturbagens
L1000 CMAP - Fibrocystic disease of breast MCF10A cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Betacellulin enhances ovarian cancer cell migration by up-regulating Connexin43 via MEK-ERK signalin…
Dysregulation of ADAM10 shedding activity in naked mole-rat fibroblasts is due to deficient phosphat…
The ABC of BTC: structural properties and biological roles of betacellulin.
Role of kisspeptin-10 and betacellulin in control of feline ovarian cell functions.
Betacellulin-Induced α-Cell Proliferation Is Mediated by ErbB3 and ErbB4, and May Contribute to β-Ce…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FOLFIRINOX for 2nd-line Treatment of BTC
BTC Neuropsychological Database
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Pati…
GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced…
GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ